These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27596738)

  • 1. Mutations at highly conserved residues in influenza A(H1N1)pdm09 virus affect neuraminidase activity.
    Romero-Beltran L; Baker SF; Puerto-Solís M; González-Losa R; Conde-Ferraez L; Alvarez-Sánchez LC; Martínez-Sobrido L; Ayora-Talavera G
    Virus Res; 2016 Oct; 225():1-9. PubMed ID: 27596738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
    McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
    Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
    J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.
    Abed Y; Pizzorno A; Bouhy X; Rhéaume C; Boivin G
    J Virol; 2014 Feb; 88(3):1652-8. PubMed ID: 24257597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.
    Matos AR; Resende PC; Miranda MD; Garcia CC; Caetano BC; Lopes JCO; Debur MC; Cury ALF; Vianna LA; Lima MC; Schirmer M; Gubareva L; Hurt AC; Brown DW; Siqueira MM
    Antiviral Res; 2018 Jun; 154():35-43. PubMed ID: 29601892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Amino Acid in the Stalk Domain of N1 Neuraminidase Is Critical for Enzymatic Activity.
    Zanin M; Duan S; Wong SS; Kumar G; Baviskar P; Collin E; Russell C; Barman S; Hause B; Webby R
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
    Abed Y; Pizzorno A; Bouhy X; Boivin G
    Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
    Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
    Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of Synergistic Secondary Antiviral Mutations in the Evolution of A(H1N1)pdm09 Influenza Virus Neuraminidases.
    Duwe SC; Milde J; Heider A; Wedde M; Schweiger B; Dürrwald R
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.
    Ginting TE; Shinya K; Kyan Y; Makino A; Matsumoto N; Kaneda S; Kawaoka Y
    J Virol; 2012 Jan; 86(1):121-7. PubMed ID: 22013054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.
    Du W; Dai M; Li Z; Boons GJ; Peeters B; van Kuppeveld FJM; de Vries E; de Haan CAM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility.
    Paradis EG; Pinilla LT; Holder BP; Abed Y; Boivin G; Beauchemin CA
    PLoS One; 2015; 10(5):e0126115. PubMed ID: 25992792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.
    Tu V; Abed Y; Fage C; Baz M; Boivin G
    Antiviral Res; 2018 Jun; 154():110-115. PubMed ID: 29674164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness.
    Tu V; Abed Y; Barbeau X; Carbonneau J; Fage C; Lagüe P; Boivin G
    Antiviral Res; 2017 Jan; 137():6-13. PubMed ID: 27838351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase amino acids 149 and 347 determine the infectivity and oseltamivir sensitivity of pandemic influenza A/H1N1 (2009) and avian influenza A/H5N1.
    Yongkiettrakul S; Nivitchanyong T; Pannengpetch S; Wanitchang A; Jongkaewwattana A; Srimanote P
    Virus Res; 2013 Aug; 175(2):128-33. PubMed ID: 23639424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
    Tandel K; Sharma S; Dash PK; Parida M
    J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.